16.66 USD
↗ 0.04 (0.21%)PRE MARKET (AS OF 03:59 AM EST)
Shares of Aktis Oncology, Inc. Common stock (AKTS) are trading at $16.66. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Nov 13, 2026.